Search by Drug Name or NDC
NDC 00281-0326-30 NITRO-BID 20 mg/g Details
NITRO-BID 20 mg/g
NITRO-BID is a TOPICAL OINTMENT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Savage Laboratories a division of Fougera Pharmaceuticals Inc.. The primary component is NITROGLYCERIN.
MedlinePlus Drug Summary
Nitroglycerin ointment (Nitro-Bid) is used to prevent episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). Nitroglycerin ointment can only be used to prevent attacks of angina; it cannot be used to treat an attack of angina once it has begun. Nitroglycerin ointment (Rectiv) is used in adults to treat pain from anal fissures (a split or tear in the tissue near the rectal area). Nitroglycerin is in a class of medications called vasodilators. Nitroglycerin ointment prevents angina by relaxing the blood vessels so that the heart does not need to work as hard and therefore does not need as much oxygen. Nitroglycerin ointment treats anal fissure pain by relaxing the blood vessels, which reduces the pressure in the anal tissues.
Related Packages: 00281-0326-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nitroglycerin Topical
Product Information
| NDC | 00281-0326 |
|---|---|
| Product ID | 0281-0326_d4bd3e47-88da-4f5a-a0eb-8e6cc0d4df79 |
| Associated GPIs | 32100030004205 |
| GCN Sequence Number | 000464 |
| GCN Sequence Number Description | nitroglycerin OINT. (G) 2 % TRANSDERM |
| HIC3 | A7B |
| HIC3 Description | VASODILATORS,CORONARY |
| GCN | 01720 |
| HICL Sequence Number | 000159 |
| HICL Sequence Number Description | NITROGLYCERIN |
| Brand/Generic | Brand |
| Proprietary Name | NITRO-BID |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Nitroglycerin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | OINTMENT |
| Route | TOPICAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/g |
| Substance Name | NITROGLYCERIN |
| Labeler Name | Savage Laboratories a division of Fougera Pharmaceuticals Inc. |
| Pharmaceutical Class | Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA087355 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00281-0326-30 (00281032630)
| NDC Package Code | 0281-0326-30 |
|---|---|
| Billing NDC | 00281032630 |
| Package | 30 g in 1 TUBE (0281-0326-30) |
| Marketing Start Date | 2009-08-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.09005 |
| Pricing Unit | GM |
| Effective Date | 2023-11-22 |
| NDC Description | NITRO-BID 2% OINTMENT |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2, 5, 6 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |